You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell vaccine

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Against Monkeypox An Observational Prospective Cohort Study

Recruiting
  • Monkeypox
    • Badalona, Barcelona, Spain
    • +1 more
    Oct 4, 2022

    Esophageal Squamous Cell Carcinoma Trial in Shanghai (Penpulimab Combined With CRT)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Penpulimab Combined With CRT
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Sep 28, 2022

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Edicotinib, Pharmacokinetic Study)

    Terminated
    Has Results
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 1, 2021

    Liver Cancer Trial (gp96)

    Not yet recruiting
    • Liver Cancer
    • gp96
    • (no location specified)
    Dec 18, 2019

    NSCLC Trial in United States (bevacizumab, Erlotinib)

    Completed
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Galloway, New Jersey
    • +6 more
    Jun 17, 2022

    Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT 60 µg, RSV MAT 120 µg, Placebo)

    Completed
    Has Results
    • Respiratory Syncytial Virus Infections
    • RSV MAT 60 µg
    • +2 more
    • Phoenix, Arizona
    • +31 more
    Nov 12, 2021

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • New York, New York
    • +15 more
    Jan 27, 2023

    Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

    Recruiting
    • Lung Cancer Non-small Cell Stage IV
      • Athens, Greece
        Hellenic Cooperative Oncology Group
      Nov 14, 2022

      B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma
      • +4 more
      • (no location specified)
      Dec 7, 2022

      NSCLC Trial in Changsha (Time of immunotherapy infusion)

      Recruiting
      • Non-small Cell Lung Cancer
      • Time of immunotherapy infusion
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Dec 7, 2022

      Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)

      Recruiting
      • Relapsed/Refractory Diffuse Large B-cell Lymphoma
      • ATG-010 and ATG-008
      • Chongqing, Chongqing, China
      • +5 more
      Sep 2, 2022

      Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical

      Recruiting
      • Hematologic Malignancy
      • Fludarabine
      • Atlanta, Georgia
        Caitlin Guzowski
      Sep 1, 2022

      Solid Tumors Trial in Worldwide (Avelumab)

      Completed
      Has Results
      • Solid Tumors
      • Goodyear, Arizona
      • +73 more
      Oct 26, 2021

      Diabetic Kidney Disease Trial in Ireland, Italy, United Kingdom (Mesenchymal Stromal Cells, Placebo)

      Recruiting
      • Diabetic Kidney Disease
      • Mesenchymal Stromal Cells
      • Placebo
      • Galway, Ireland
      • +3 more
      Jul 13, 2021

      Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

      Not yet recruiting
      • Diffuse Large B-cell Lymphoma
      • (no location specified)
      Mar 23, 2023

      Giant Cell Tumor of Bone Trial (Dietary Supplement: Calcium/Vitamin D)

      Active, not recruiting
      • Giant Cell Tumor of Bone
      • Dietary Supplement: Calcium/Vitamin D
      • Beijing, China
        Beijing Ji Shui Tan Hospital
      Oct 13, 2022

      Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Jun 9, 2022

      BCC - Basal Cell Carcinoma, BCC, Excision Margin Trial in United States (CellFX System)

      Completed
      Has Results
      • BCC - Basal Cell Carcinoma
      • +2 more
      • CellFX System
      • Vestavia Hills, Alabama
      • +4 more
      Dec 15, 2022

      Handgrip Strength, Skinfold Thickness and Trunk Strength

      Completed
      • Young Adult
      • hand grip strength
      • Abha, Aseer, Saudi Arabia
        King Khalid University
      Jan 29, 2022

      Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

      Recruiting
      • Glioblastoma Multiforme of Brain
      • Autologous dendritic cells pulsed with multiple neoantigen peptides.
      • Temozolomide adjuvant chemotherapy
      • Beijing, Beijing, China
        Beijing Tiantan Hospital
      Jan 13, 2022

      Rift Valley Fever Trial in Oxford (ChAdOx1 RVF)

      Completed
      • Rift Valley Fever
      • ChAdOx1 RVF
      • Oxford, United Kingdom
        CCVTM, University of Oxford, Churchill Hospital
      Apr 27, 2022

      PET Tracer Based FDG Signal for Predicting Prognosis in Acute

      Enrolling by invitation
      • Acute Myeloid Leukemia
      • No intervention
      • Guangzhou, Guangdong, China
        First Affiliated Hospital of Jinan University
      Jun 22, 2023

      Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)

      Not yet recruiting
      • Clinical Stage IIA Cutaneous Melanoma AJCC v8
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Nov 27, 2023

      Reflex, Abnormal Trial in Istanbul (Electrodiagnostic test)

      Completed
      • Reflex, Abnormal
      • Electrodiagnostic test
      • İstanbul, Turkey
        Istanbul Physical Medicine Rehabilitation Training and Research
      Aug 30, 2021